May 7, 2026 09:00AM
May 7, 2026 09:00AM
Apr 21, 2026 07:00AM
Apr 1, 2026 06:45AM
Apr 1, 2026 06:45AM
Mar 30, 2026 08:47AM
Mar 30, 2026 08:45AM KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
Mar 18, 2026 09:00AM
Mar 18, 2026 08:15AM
Mar 11, 2026 06:31AM
Mar 11, 2026 06:30AM
Mar 4, 2026 06:30AM
Mar 4, 2026 06:30AM
Dec 5, 2025 02:37PM KALA BIO closes $10 million stock offering at $1 per share
Dec 5, 2025 02:36PM
Dec 4, 2025 10:45AM
Dec 4, 2025 10:45AM
Dec 1, 2025 07:01AM
Dec 1, 2025 07:00AM
Sep 29, 2025 08:06AM
Sep 29, 2025 08:00AM KALA BIO Announces Topline Results from CHASE Phase 2b Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) Did Not Meet Primary Endpoint
Sep 3, 2025 08:00AM
Sep 2, 2025 08:00AM
Sep 2, 2025 08:00AM
Sep 2, 2025 08:00AM
Aug 8, 2025 08:00AM
Aug 6, 2025 08:00AM
Jul 9, 2025 08:03AM KALA BIO completes enrollment in CHASE trial for eye disease treatment
Jul 9, 2025 08:00AM
Jul 7, 2025 08:00AM
Jun 2, 2025 08:53AM
May 29, 2025 08:00AM
May 14, 2025 08:00AM
Apr 14, 2025 06:32AM
Apr 1, 2025 10:29AM Oppenheimer Reiterates Outperform Rating on Kala Pharmaceuticals (KALA), PT $15
Mar 31, 2025 08:00AM
Feb 26, 2025 08:00AM
Feb 12, 2025 08:02AM
Feb 12, 2025 08:00AM
Dec 30, 2024 08:01AM
Dec 30, 2024 08:00AM
Nov 27, 2024 08:00AM KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference
Nov 18, 2024 07:37AM
Nov 12, 2024 08:00AM
Aug 8, 2024 08:00AM
Aug 7, 2024 06:48AM
Aug 6, 2024 08:00AM
Jun 27, 2024 08:01AM
Jun 27, 2024 08:00AM KALA BIO Announces $12,500,000 Private Placement
May 29, 2024 08:00AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All